Subject: News Release for Contagious Gaming
PDF Document
File: Attachment 20260312 Contagious Gaming Inc. - PR - IMB RTO v.Final.pdf
CONTAGIOUS GAMING UPDATE ON TRANSACTION WITH IMBIOTECHNOLOGIES
NOT FOR DISSEMINATION IN THE US OR THROUGH US NEWSWIRE SERVICES
VANCOUVER, B.C., March 12, 2026 Contagious Gaming Inc. (TSX-V: CNS) ("Contagious Gaming" or
the "Company") is pleased to provide an update regarding the previously announced proposed
combination with IMBiotechnologies Ltd. ("IMBiotechnologies").
As previously announced on July 17, 2024, the Company entered into a non-binding letter of intent with
IMBiotechnologies pursuant to which the parties intend to complete a transaction that would constitute
a reverse takeover of the Company (the "Transaction").
The Company and IMBiotechnologies continue to advance the Transaction and remain engaged in
negotiations toward the execution of a definitive agreement. The parties are also continuing their
respective due diligence investigations and working with advisors to determine the optimal legal
structure for the Transaction.
In parallel with the Transaction, IMBiotechnologies continues to evaluate and advance plans for a
concurrent financing, the proceeds of which are expected to be used to support commercialization
activities and general corporate purposes.
The completion of the Transaction remains subject to a number of conditions, including but not limited
to:
dot negotiation and execution of a definitive agreement;
dot completion of satisfactory due diligence by both parties;
dot completion of any required financing;
dot receipt of all required shareholder and regulatory approvals; and
dot satisfaction of other customary closing conditions.
There can be no assurance that the Transaction will be completed as proposed or at all.
Trading in the Company's common shares remains halted in accordance with the policies of the TSX
Venture Exchange and is expected to remain halted until such time as the Exchange determines that
trading may resume.
The Company will provide further updates as material developments occur.
About Contagious Gaming
Contagious Gaming Inc. (TSX-V: CNS) is in the business of developing and investing software solutions for
regulated gaming and lottery markets. The Company is focused on leveraging its existing assets for the
B2B gaming marketplace.
For more information on Contagious Gaming please visit www.contagiousgaming.com.
For further information, please contact:
Craig Loverock, Chief Financial Officer
Email: craig.loverock@contagiousgaming.com
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the
policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Forward-Looking Statements
This information release contains certain forward-looking information, including about the Offering, the
receipt of all necessary regulatory approvals and the expected use of proceeds from the Offering. Such
information involves known and unknown risks, uncertainties and other factors that may cause actual
results, performance or achievements to be materially different from those implied by statements
herein, and therefore these statements should not be read as guarantees of future performance or
results. All forward-looking statements are based on the Company's current beliefs as well as
assumptions made by and information currently available to it as well as other factors. Readers are
cautioned not to place undue reliance on these forward-looking statements, which speak only as of the
date of this press release. Due to risks and uncertainties, including the risks and uncertainties identified
by the Company in its public securities filings, actual events may differ materially from current
expectations. The Company disclaims any intention or obligation to update or revise any forward-looking
statements, whether as a result of new information, future events or otherwise.
© 2026 Canjex Publishing Ltd. All rights reserved.